BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer

Background: Biglycan (BGN) plays a role in the occurrence and progression of several malignant tumors, though its role in gastric cancer (GC) remains unclear. The objective of this study was to investigate BGN expression, its role in GC prognosis, and immune infiltration. Material and Methods: Gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shiyu, Yang, Huiying, Xiang, Xuelian, Liu, Li, Huang, Huali, Tang, Guodu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826557/
https://www.ncbi.nlm.nih.gov/pubmed/35154268
http://dx.doi.org/10.3389/fgene.2022.765569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826557/
https://www.ncbi.nlm.nih.gov/pubmed/35154268
http://dx.doi.org/10.3389/fgene.2022.765569

Ejemplares similares